3rd Microbiome R&D and Business Collaboration Congress: Asia
01 March 2017 - 02 March 2017Summary
This two-day, interactive meeting, will provide the opportunity to examine the latest research into microbial communities with a focus on translation to therapeutics. Across two separate tracks, key topics such as commercialisation, diet, and R&D, inside and outside the gut, will be covered.
In addition, there will be a vibrant exhibition room and senior-level panel discussions, providing numerous opportunities to network and form partnerships.Overview
Building on the success of our 2015 and 2016 congresses, Global Engage is pleased to announce the 3rd Microbiome R&D and Business Collaboration Congress: Asia, which will be held on March 1 – 2, 2017 in Hong Kong and co-located with our 2nd Probiotics Congress. Last year’s successful event attracted over 200 attendees.
Developments in the field of metagenomics have allowed researchers to explore the diverse microbiota in the human body. Research has shown that the microbiome is linked to natural immunity, metabolism, behavioural traits, and broadly speaking, plays an instrumental role in health and disease. With large-scale collaborative projects underway and sequencing data placed in the public domain, there is a rich source of information for researchers and companies looking for opportunities in this exciting field. Increasingly, there are indications that the human microbiome is key to curative and preventative medicine so efforts are being focused on expanding investment opportunities, performing more clinical trials and spurring innovative research in this area. Coupled with an increasing focus on healthy living and a therapeutics market that is expected to grow to $1.2 trillion by 2016, microbiome research is set to make waves in the science and medical world through its application in preventative treatments, cures, therapies and supplements. More Information »